| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.36B | 25.75B | 24.04B | 19.69B | 20.71B | 22.99B |
| Gross Profit | 25.25B | 25.52B | 23.78B | 19.43B | 20.51B | 23.07B |
| EBITDA | 9.92B | 9.36B | 8.32B | 5.46B | 6.10B | 7.94B |
| Net Income | 7.08B | 6.72B | 5.55B | 3.56B | 3.76B | 5.36B |
Balance Sheet | ||||||
| Total Assets | 192.50B | 185.45B | 208.11B | 183.51B | 182.48B | 193.03B |
| Cash, Cash Equivalents and Short-Term Investments | 6.96B | 10.23B | 10.17B | 10.27B | 16.58B | 13.18B |
| Total Debt | 17.53B | 26.01B | 30.40B | 33.40B | 29.04B | 30.12B |
| Total Liabilities | 126.19B | 117.75B | 141.77B | 125.95B | 125.98B | 136.83B |
| Stockholders Equity | 66.31B | 67.70B | 66.34B | 57.56B | 56.50B | 56.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.41B | 1.05B | -5.89B | 5.93B | 3.13B |
| Operating Cash Flow | 0.00 | 3.13B | 1.58B | -5.80B | 6.36B | 3.96B |
| Investing Cash Flow | 0.00 | -666.00M | 3.02B | -2.39B | -1.14B | -1.02B |
| Financing Cash Flow | 0.00 | -2.82B | -1.89B | -1.73B | -2.75B | -2.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥88.08B | 6.63 | ― | 5.75% | 10.85% | 30.77% | |
80 Outperform | ¥191.60B | 6.74 | ― | 4.01% | -2.39% | -4.54% | |
76 Outperform | ¥2.12T | 10.19 | 9.37% | 4.13% | -0.87% | 6.88% | |
74 Outperform | ¥252.69B | 12.14 | 14.00% | 5.13% | 3.27% | -1.81% | |
69 Neutral | ¥3.62T | 10.42 | 10.23% | 3.93% | -2.45% | 35.60% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
43 Neutral | ¥177.49B | 13.27 | 7.26% | 4.16% | 14.69% | -114.36% |